Diabetes Clinical Trials in Detroit

Showing 421-440 of 608 trials

Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®

NCT01898286

This is an extension study to evaluate the safety and tolerability of long-term treatment with DiaPep277® and to determine the long-term treatment effect of DiaPep277® on parameters of metabolic control and on preservation of beta-cell function in subjects who have long exposure to DiaPep277®.

Type 1 Diabetes

Andromeda Biotech Ltd.38 participantsStarted Oct 2013

Atlanta, Georgia, United States • Detroit, Michigan, United States • Asheville, North Carolina, United States

COMPLETEDPhase 36.7 miles

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).

NCT01131676

The aim of the present study is to investigate the safety of BI 10773 treatment in patients with Type 2 Diabetes Mellitus and high cardiovascular risk.

Diabetes Mellitus, Type 2

Boehringer Ingelheim7,064 participantsStarted Jul 2010

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +612 more locations

Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).

Diabetes Trials in Other Cities

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus

Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)

T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus

Multiple Ascending Dose Study in Subjects With Type 2 Diabetes

Strategies to Improve Islet Survival

Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder

A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

Glucose Meter Study

G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator

Other Conditions in Detroit